Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001190694 | SCV001358263 | likely benign | Cardiomyopathy | 2018-11-09 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001401960 | SCV001603799 | likely benign | Charcot-Marie-Tooth disease type 2 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411718 | SCV002715628 | likely benign | Cardiovascular phenotype | 2020-02-08 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV001699519 | SCV001926032 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724264 | SCV001954395 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001724264 | SCV001978168 | likely benign | not provided | no assertion criteria provided | clinical testing |